Condition: Chronic Obstructive Pulmonary Disease · Sponsor: Maria Joyera Rodríguez
The 3TR-ICS COPD study is an international, multicentre, randomized, parallel, controlled study that will recruit clinically stable former smokers COPD patients (with no exacerbations in the previous 8 weeks) on treatment with dual long-acting bronchodilators (LABA+LAMA), minimum 8 weeks of usage, not receiving ICS (either naïve or \> 3 months since last usage). The overall objective of this clinical trial is to identify the molecular signatures associated with the molecular response to ICS treatment in patients with COPD stratified by the levels of circulating eosinophils, and the potential influence of the pulmonary microbiome
This description comes directly from the study's public registry record.
Rosa Faner · +34932775400 · rfaner@recerca.clinic.cat
Maria Joyera · joyera@recerca.clinic.cat
Always discuss trial participation with your own doctor first.
| Philips University of Marburg | Marburg, Germany | Recruiting |
| Academisch Ziekenhuis Groningen | Groningen, Netherlands | Recruiting |
| Clínic Barcelona | Barcelona, Spain | Recruiting |
| Son Espases | Palma de Mallorca, Spain | Recruiting |
| University of Leicester | Leicester, United Kingdom | Not Yet Recruiting |
| Imperial College London | London, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06334575